These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 16684076

  • 1. The CARI guidelines. Biochemical targets.
    Hawley C, Elder G, Caring for Australasians with Renal Impairment (CARI).
    Nephrology (Carlton); 2006 Apr; 11 Suppl 1():S198-216. PubMed ID: 16684076
    [No Abstract] [Full Text] [Related]

  • 2. The CARI guidelines. Management of bone disease, calcium, phosphate and parathyroid hormone.
    Elder G, Faull R, Branley P, Hawley C, Caring for Australasians with Renal Impairment (CARI).
    Nephrology (Carlton); 2006 Apr; 11 Suppl 1():S230-61. PubMed ID: 16684078
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Progress of renal osteodystrophy during continuous ambulatory peritoneal dialysis.
    Buccianti G, Bianchi ML, Valenti G.
    Clin Nephrol; 1984 Dec; 22(6):279-83. PubMed ID: 6525771
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of renal osteodystrophy in advanced renal failure during predialysis time.
    Fröhling PT, Kokot F, Vetter K, Hohmann WD, Werner G, Grossmann I, Schmicker R, Lindenau K.
    Contrib Nephrol; 1984 Dec; 37():62-5. PubMed ID: 6609046
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of dialysis prescription on bone and mineral metabolism: the National Cooperative Dialysis Study.
    Harter HR, Laird NM, Teehan BP.
    Kidney Int Suppl; 1983 Apr; (13):S73-9. PubMed ID: 6345900
    [No Abstract] [Full Text] [Related]

  • 12. [Renal osteopathy and bone mineralisation in patients treated with dihydrotachysterol during long term dialysis (author's transl)].
    Pogglitsch H, Schmidberger H, Gell G.
    MMW Munch Med Wochenschr; 1976 Jan 30; 118(5):131-6. PubMed ID: 814443
    [Abstract] [Full Text] [Related]

  • 13. Clinical problems of renal osteopathy in patients on hemofiltration.
    Schulz W, Baier E, Hümpfner A, Delling G.
    Contrib Nephrol; 1982 Jan 30; 32():86-91. PubMed ID: 7128166
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Assessment of phosphorus and calcium metabolism and its clinical management in hemodialysis patients in the community of Valencia.
    Maduell F, Gorriz JL, Pallardo LM, Pons R, Santiago C, Multicentric group for the study of the phosphocalcic metabolism in the community of Valencia.
    J Nephrol; 2005 Jan 30; 18(6):739-48. PubMed ID: 16358233
    [Abstract] [Full Text] [Related]

  • 16. Do differences in dialysis prescription impact on KDOQI bone mineral targets? The Pan Thames Renal Audit.
    Davenport A, Gardner C, Delaney M, Pan Thames Renal Audit Group.
    Blood Purif; 2010 Jan 30; 30(2):111-7. PubMed ID: 20714141
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.